4.5 Article

Precipitation of a Monoclonal Antibody by Soluble Tungsten

期刊

JOURNAL OF PHARMACEUTICAL SCIENCES
卷 98, 期 9, 页码 3290-3301

出版社

ELSEVIER SCIENCE INC
DOI: 10.1002/jps.21707

关键词

protein aggregation; microparticles; protein delivery; injectables; injectors; tungsten; monoclonal antibody; syringe; contamination; precipitation

资金

  1. Graduate Assistantship in Areas of National Need (GAANN) program
  2. NIH [NIH T32 GM008732, I R01 EB006006-01]
  3. Amgen Inc

向作者/读者索取更多资源

Tungsten microparticles may be introduced into some pre-filled syringes during the creation of the needle hole. In turn, these microcontaminants may interact with protein therapeutics to produce visible particles. We found that soluble tungsten polyanions formed in acidic buffer below pH 6.0 can precipitate a monoclonal antibody within seconds. Soluble tungsten in pH 5.0 buffer at about 3 ppm was enough to cause precipitation of a mAb formulated at 0.02 mg/mL. The secondary structure of the protein was near-native in the collected precipitate. Our observations are consistent with the coagulation of a monoclonal antibody by tungsten polyanions. Tungsten-induced precipitation should only be a concern for proteins formulated below about pH 6.0 since tungsten polyanions are not formed at higher pHs. We speculate that the heterogenous nature of particle contamination within the poorly mixed syringe tip volume could mean that a specification for tungsten contamination based on the entire syringe volume is not appropriate. The potential potency of tungsten metal contamination is highlighted by the small number of particles that would be required to generate soluble tungsten levels needed to coagulate this antibody at pH 5.0. (C) 2009 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 98:3290-3301, 2009

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据